Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 03, 2019 Filed Sep 5, 2019 20:30 UTC |
Heino Mary AnneDirector · President & CEO
|
SaleCommon Stock | 25,538 | $21.21 | $541,678.86 |
DisclosureSEC source: 0000899243-19-022833 · doc4.xml · nonDerivative · entry 1 Heino Mary Anne · CIK 0001610676 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 597,884 F1 · kind: Starting in 2019, the Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions under 10b5-1 plans. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2019, to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.84 to $21.54, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| July 10, 2019 Filed Jul 12, 2019 16:05 UTC |
MARKISON BRIAN ADirector
|
SaleCommon Stock | 4,918 | $28.07 | $138,048.26 |
DisclosureSEC source: 0000899243-19-019527 · doc4.xml · nonDerivative · entry 1 MARKISON BRIAN A · CIK 0001283061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,549 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.07 to $28.15, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc. ("LNTH"), any security holder of LNTH or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| July 10, 2019 Filed Jul 12, 2019 16:13 UTC |
DUFFY MICHAEL PSVP and General Counsel
|
SaleCommon Stock | 8,819 | $28.14 | $248,166.66 |
DisclosureSEC source: 0000899243-19-019536 · doc4.xml · nonDerivative · entry 1 DUFFY MICHAEL P · CIK 0001237200 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,494 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 1, 2019. Read SEC document |
| July 08, 2019 Filed Jul 10, 2019 20:05 UTC |
Orlandi CesareChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 8,896 | $0.00 Strike: $18.66 | $0.00 |
DisclosureSEC source: 0000899243-19-019423 · doc4.xml · derivative · entry 10 Orlandi Cesare · CIK 0001610664 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,896 shares Expires 2023-08-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 7, 2019. F6 · derivative.exercise_date: These options vested in four equal installments on August 5, 2014, 2015, 2016 and 2017. Read SEC document |
| July 08, 2019 Filed Jul 10, 2019 20:05 UTC |
Orlandi CesareChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,672 | $0.00 Strike: $21.10 | $0.00 |
DisclosureSEC source: 0000899243-19-019423 · doc4.xml · derivative · entry 9 Orlandi Cesare · CIK 0001610664 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,672 shares Expires 2023-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 7, 2019. F5 · derivative.exercise_date: Options to purchase 13,345 shares of Common Stock were granted to the reporting person on March 4, 2013, which options were subject to vesting in up to four equal annual installments based upon the level of LNTH's satisfaction of certain performance criteria for each of fiscal years 2013, 2014, 2015 and 2016. A certain level of the performance criteria were satisfied for each of fiscal years 2013 and 2014, resulting in the partial vesting as to 6,672 shares of Common Stock. Read SEC document |
| July 08, 2019 Filed Jul 10, 2019 20:05 UTC |
Orlandi CesareChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 13,346 | $0.00 Strike: $21.10 | $0.00 |
DisclosureSEC source: 0000899243-19-019423 · doc4.xml · derivative · entry 8 Orlandi Cesare · CIK 0001610664 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,346 shares Expires 2023-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 7, 2019. F4 · derivative.exercise_date: These options vested in four equal installments on March 4, 2014, 2015, 2016 and 2017. Read SEC document |
| July 08, 2019 Filed Jul 10, 2019 20:05 UTC |
Orlandi CesareChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,672 | $0.00 Strike: $21.10 | $0.00 |
DisclosureSEC source: 0000899243-19-019423 · doc4.xml · derivative · entry 7 Orlandi Cesare · CIK 0001610664 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,672 shares Expires 2023-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 7, 2019. Read SEC document |
| July 08, 2019 Filed Jul 10, 2019 20:05 UTC |
Orlandi CesareChief Medical Officer
|
SaleCommon Stock | 7,584 | $27.60 | $209,318.40 |
DisclosureSEC source: 0000899243-19-019423 · doc4.xml · nonDerivative · entry 6 Orlandi Cesare · CIK 0001610664 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,483 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 7, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.06 to $27.99, inclusive. The reporting person undertakes to provide to LNTH, any security holder of LNTH or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. Read SEC document |
| July 08, 2019 Filed Jul 10, 2019 20:05 UTC |
Orlandi CesareChief Medical Officer
|
SaleCommon Stock | 28,002 | $28.33 | $793,296.66 |
DisclosureSEC source: 0000899243-19-019423 · doc4.xml · nonDerivative · entry 5 Orlandi Cesare · CIK 0001610664 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,067 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 7, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.45, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc. ("LNTH"), any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| July 08, 2019 Filed Jul 10, 2019 20:05 UTC |
Orlandi CesareChief Medical Officer
|
Exercise / conversionCommon Stock | 8,896 | $21.10 | $187,705.60 |
DisclosureSEC source: 0000899243-19-019423 · doc4.xml · nonDerivative · entry 4 Orlandi Cesare · CIK 0001610664 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,069 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 7, 2019. Read SEC document |
| July 08, 2019 Filed Jul 10, 2019 20:05 UTC |
Orlandi CesareChief Medical Officer
|
Exercise / conversionCommon Stock | 6,672 | $21.10 | $140,779.20 |
DisclosureSEC source: 0000899243-19-019423 · doc4.xml · nonDerivative · entry 3 Orlandi Cesare · CIK 0001610664 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,173 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 7, 2019. Read SEC document |
| July 08, 2019 Filed Jul 10, 2019 20:05 UTC |
Orlandi CesareChief Medical Officer
|
Exercise / conversionCommon Stock | 13,346 | $21.10 | $281,600.60 |
DisclosureSEC source: 0000899243-19-019423 · doc4.xml · nonDerivative · entry 2 Orlandi Cesare · CIK 0001610664 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,501 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 7, 2019. Read SEC document |
| July 08, 2019 Filed Jul 10, 2019 20:05 UTC |
Orlandi CesareChief Medical Officer
|
Exercise / conversionCommon Stock | 6,672 | $21.10 | $140,779.20 |
DisclosureSEC source: 0000899243-19-019423 · doc4.xml · nonDerivative · entry 1 Orlandi Cesare · CIK 0001610664 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,155 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 7, 2019. Read SEC document |
| July 03, 2019 Filed Jul 5, 2019 16:05 UTC |
MARKISON BRIAN ADirector
|
SaleCommon Stock | 5,000 | $28.41 | $142,050.00 |
DisclosureSEC source: 0000899243-19-019244 · doc4.xml · nonDerivative · entry 1 MARKISON BRIAN A · CIK 0001283061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,467 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019. Read SEC document |
| June 26, 2019 Filed Jun 28, 2019 16:30 UTC |
MARKISON BRIAN ADirector
|
SaleCommon Stock | 5,000 | $27.67 | $138,361.00 |
DisclosureSEC source: 0000899243-19-018534 · doc4.xml · nonDerivative · entry 1 MARKISON BRIAN A · CIK 0001283061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,467 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.62 to $27.81, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| June 20, 2019 Filed Jun 24, 2019 20:30 UTC |
Heino Mary AnneDirector · President & CEO
|
SaleCommon Stock | 1,575 | $28.48 | $44,856.00 |
DisclosureSEC source: 0000899243-19-017934 · doc4.xml · nonDerivative · entry 2 Heino Mary Anne · CIK 0001610676 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 623,422 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2019. Read SEC document |
| June 20, 2019 Filed Jun 24, 2019 20:30 UTC |
Heino Mary AnneDirector · President & CEO
|
SaleCommon Stock | 12,765 | $27.82 | $355,078.90 |
DisclosureSEC source: 0000899243-19-017934 · doc4.xml · nonDerivative · entry 1 Heino Mary Anne · CIK 0001610676 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 624,997 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.385 to $28.32, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 20:32 UTC |
Bolla John J.Chief Operations Officer
|
SaleCommon Stock | 128 | $27.32 | $3,496.96 |
DisclosureSEC source: 0000899243-19-017656 · doc4.xml · nonDerivative · entry 2 Bolla John J. · CIK 0001741843 · Chief Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,027 F1 · kind: Starting in 2019, the Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions in compliance with Rule 10b5-1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2018, to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 16:30 UTC |
MARKISON BRIAN ADirector
|
SaleCommon Stock | 5,000 | $27.40 | $137,014.50 |
DisclosureSEC source: 0000899243-19-017814 · doc4.xml · nonDerivative · entry 1 MARKISON BRIAN A · CIK 0001283061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,467 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.40 to $27.43, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| June 18, 2019 Filed Jun 20, 2019 20:32 UTC |
Bolla John J.Chief Operations Officer
|
SaleCommon Stock | 1,619 | $27.58 | $44,652.02 |
DisclosureSEC source: 0000899243-19-017656 · doc4.xml · nonDerivative · entry 1 Bolla John J. · CIK 0001741843 · Chief Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,155 F1 · kind: Starting in 2019, the Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions in compliance with Rule 10b5-1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2018, to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4. Read SEC document |
| June 18, 2019 Filed Jun 27, 2019 20:38 UTC Amendment |
Bolla John J.Chief Operations Officer
|
SaleCommon Stock | 2,241 | $27.58 | $61,806.78 |
DisclosureSEC source: 0000899243-19-018377 · doc4a.xml · nonDerivative · entry 1 Bolla John J. · CIK 0001741843 · Chief Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,405 F1 · kind: Starting in 2019, the Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions in compliance with Rule 10b5-1. The transactions reported in this Form 4 were effected in compliance with Rule 10b5-1 to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4 F2 · shares: The Form 4 originally filed on June 20, 2019 inadvertently reported 1,619 shares disposed on June 18, 2019. The correct amount of shares disposed on June 18, 2019, is 2,241 and is being reported in this amendment. F3 · balance_after: The number of shares beneficially owned is being updated to reflect the correct number beneficially owned, after giving effect to the transaction on June 19, 2019 previously reported on the original Form 4. Read SEC document |
| June 12, 2019 Filed Jun 14, 2019 16:30 UTC |
MARKISON BRIAN ADirector
|
SaleCommon Stock | 5,000 | $25.27 | $126,365.00 |
DisclosureSEC source: 0000899243-19-017062 · doc4.xml · nonDerivative · entry 1 MARKISON BRIAN A · CIK 0001283061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,467 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.18 to $25.30, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| June 07, 2019 Filed Jun 11, 2019 16:32 UTC |
LENO SAM RDirector
|
SaleCommon Stock | 3,950 | $25.33 | $100,059.43 |
DisclosureSEC source: 0000899243-19-016392 · doc4.xml · nonDerivative · entry 1 LENO SAM R · CIK 0001238660 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,580 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.12 to $25.70, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| June 05, 2019 Filed Jun 7, 2019 16:30 UTC |
SCHAFFER DERACE LDirector
|
SaleCommon Stock | 10,000 | $24.71 | $247,127.00 |
DisclosureSEC source: 0000899243-19-016022 · doc4.xml · nonDerivative · entry 1 SCHAFFER DERACE L · CIK 0001031735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,994 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 1, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.36 to $24.84, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| June 05, 2019 Filed Jun 7, 2019 16:30 UTC |
MARKISON BRIAN ADirector
|
SaleCommon Stock | 5,000 | $24.60 | $123,009.50 |
DisclosureSEC source: 0000899243-19-016021 · doc4.xml · nonDerivative · entry 1 MARKISON BRIAN A · CIK 0001283061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,467 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.43 to $24.825, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| June 04, 2019 Filed Jun 5, 2019 16:30 UTC |
SCHAFFER DERACE LDirector
|
SaleCommon Stock | 1,080 | $24.61 | $26,578.15 |
DisclosureSEC source: 0000899243-19-015598 · doc4.xml · nonDerivative · entry 3 SCHAFFER DERACE L · CIK 0001031735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,994 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 1, 2019. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.59 to $24.65 , inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4. Read SEC document |
| June 04, 2019 Filed Jun 5, 2019 16:30 UTC |
SCHAFFER DERACE LDirector
|
SaleCommon Stock | 8,920 | $24.11 | $215,080.82 |
DisclosureSEC source: 0000899243-19-015598 · doc4.xml · nonDerivative · entry 2 SCHAFFER DERACE L · CIK 0001031735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,074 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 1, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.59 to $24.58 , inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 16:30 UTC |
SCHAFFER DERACE LDirector
|
SaleCommon Stock | 10,000 | $23.47 | $234,725.00 |
DisclosureSEC source: 0000899243-19-015598 · doc4.xml · nonDerivative · entry 1 SCHAFFER DERACE L · CIK 0001031735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,994 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 1, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.25 to $23.78, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| May 29, 2019 Filed May 31, 2019 16:30 UTC |
MARKISON BRIAN ADirector
|
SaleCommon Stock | 5,000 | $24.29 | $121,453.50 |
DisclosureSEC source: 0000899243-19-015291 · doc4.xml · nonDerivative · entry 1 MARKISON BRIAN A · CIK 0001283061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,467 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.25 to $24.41, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| May 22, 2019 Filed May 24, 2019 16:30 UTC |
MARKISON BRIAN ADirector
|
SaleCommon Stock | 5,000 | $24.73 | $123,627.50 |
DisclosureSEC source: 0000899243-19-014739 · doc4.xml · nonDerivative · entry 1 MARKISON BRIAN A · CIK 0001283061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,467 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.65 to $24.785, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| May 20, 2019 Filed May 22, 2019 20:30 UTC |
Heino Mary AnneDirector · President & CEO
|
SaleCommon Stock | 16,827 | $23.89 | $401,939.82 |
DisclosureSEC source: 0000899243-19-014346 · doc4.xml · nonDerivative · entry 1 Heino Mary Anne · CIK 0001610676 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 637,762 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.66 to $24, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| May 15, 2019 Filed May 17, 2019 16:31 UTC |
MARKISON BRIAN ADirector
|
SaleCommon Stock | 5,000 | $24.75 | $123,754.50 |
DisclosureSEC source: 0000899243-19-014003 · doc4.xml · nonDerivative · entry 1 MARKISON BRIAN A · CIK 0001283061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,467 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.75 to $24.765, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| May 08, 2019 Filed May 10, 2019 16:31 UTC |
MARKISON BRIAN ADirector
|
SaleCommon Stock | 5,000 | $25.22 | $126,115.50 |
DisclosureSEC source: 0000899243-19-013046 · doc4.xml · nonDerivative · entry 1 MARKISON BRIAN A · CIK 0001283061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,467 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.20 to $25.27, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| May 01, 2019 Filed May 2, 2019 16:30 UTC |
MARKISON BRIAN ADirector
|
SaleCommon Stock | 5,000 | $23.91 | $119,537.00 |
DisclosureSEC source: 0000899243-19-011782 · doc4.xml · nonDerivative · entry 2 MARKISON BRIAN A · CIK 0001283061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,467 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.815 to $24.13, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. Read SEC document |
| April 30, 2019 Filed May 2, 2019 16:30 UTC |
MARKISON BRIAN ADirector
|
SaleCommon Stock | 5,000 | $24.30 | $121,519.00 |
DisclosureSEC source: 0000899243-19-011782 · doc4.xml · nonDerivative · entry 1 MARKISON BRIAN A · CIK 0001283061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,467 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.25 to $24.35, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| April 29, 2019 Filed May 1, 2019 16:30 UTC |
DUFFY MICHAEL PSee Remarks
|
SaleCommon Stock | 6,908 | $24.84 | $171,615.44 |
DisclosureSEC source: 0000899243-19-011589 · doc4.xml · nonDerivative · entry 1 DUFFY MICHAEL P · CIK 0001237200 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,313 F1 · kind: Starting in 2019, the Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions in compliance with Rule 10b5-1. The transactions reported in this Form 4 were effected in compliance with Rule 10b5-1 to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4. Read SEC document |
| April 29, 2019 Filed May 1, 2019 20:30 UTC |
Orlandi CesareChief Medical Officer
|
SaleCommon Stock | 11,250 | $24.85 | $279,616.50 |
DisclosureSEC source: 0000899243-19-011590 · doc4.xml · nonDerivative · entry 1 Orlandi Cesare · CIK 0001610664 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,483 F1 · kind: Starting in 2019, the Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions under 10b5-1 plans. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2018, in part, to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.37 to $25.23, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| April 26, 2019 Filed Apr 30, 2019 20:30 UTC |
Heino Mary AnneDirector · President & CEO
|
SaleCommon Stock | 29,813 | $24.86 | $741,073.67 |
DisclosureSEC source: 0000899243-19-011444 · doc4.xml · nonDerivative · entry 1 Heino Mary Anne · CIK 0001610676 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 654,589 F1 · kind: Starting in 2019, the Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions under 10b5-1 plans. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2019, to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.51 to $25.22, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| April 23, 2019 Filed Apr 25, 2019 16:30 UTC |
MARKISON BRIAN ADirector
|
SaleCommon Stock | 5,000 | $24.07 | $120,368.00 |
DisclosureSEC source: 0000899243-19-011133 · doc4.xml · nonDerivative · entry 1 MARKISON BRIAN A · CIK 0001283061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,467 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.00 to $24.11, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 16:30 UTC |
MARKISON BRIAN ADirector
|
SaleCommon Stock | 5,000 | $25.26 | $126,297.50 |
DisclosureSEC source: 0000899243-19-010897 · doc4.xml · nonDerivative · entry 1 MARKISON BRIAN A · CIK 0001283061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,467 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.25 to $25.40, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| April 12, 2019 Filed Apr 16, 2019 20:30 UTC |
Heino Mary AnneDirector · President & CEO
|
SaleCommon Stock | 15,799 | $25.40 | $401,316.72 |
DisclosureSEC source: 0000899243-19-010687 · doc4.xml · nonDerivative · entry 1 Heino Mary Anne · CIK 0001610676 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 684,402 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.07 to $25.66, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 16:30 UTC |
SCHAFFER DERACE LDirector
|
SaleCommon Stock | 10,000 | $24.41 | $244,094.00 |
DisclosureSEC source: 0000899243-19-009765 · doc4.xml · nonDerivative · entry 1 SCHAFFER DERACE L · CIK 0001031735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,994 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.11 to $25.00, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 16:32 UTC |
Pruden Gary JDirector
|
SaleCommon Stock | 3,192 | $22.77 | $72,672.26 |
DisclosureSEC source: 0000899243-19-006914 · doc4.xml · nonDerivative · entry 1 Pruden Gary J · CIK 0001673416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,072 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.58 to $23.01, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 21:33 UTC |
McHugh JulieDirector
|
SaleCommon Stock | 2,595 | $22.77 | $59,075.18 |
DisclosureSEC source: 0000899243-19-006915 · doc4.xml · nonDerivative · entry 1 McHugh Julie · CIK 0001487179 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,510 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.57 to $23.01, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 16:32 UTC |
Thrall James HDirector
|
SaleCommon Stock | 3,500 | $22.78 | $79,723.00 |
DisclosureSEC source: 0000899243-19-006912 · doc4.xml · nonDerivative · entry 1 Thrall James H · CIK 0001315048 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,764 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.58 to $23.02, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 16:32 UTC |
DUFFY MICHAEL PSee Remarks
|
SaleCommon Stock | 1,789 | $22.77 | $40,733.74 |
DisclosureSEC source: 0000899243-19-006913 · doc4.xml · nonDerivative · entry 1 DUFFY MICHAEL P · CIK 0001237200 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,221 F1 · kind: Starting in 2019, the Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions under 10b5-1 plans. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2018, to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.58 to $23.04, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 16:30 UTC |
Robertson A FrederickDirector
|
SaleCommon Stock | 3,932 | $22.77 | $89,535.57 |
DisclosureSEC source: 0000899243-19-006908 · doc4.xml · nonDerivative · entry 1 Robertson A Frederick · CIK 0001396084 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,062 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.57 to $23.02, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 21:35 UTC |
Orlandi CesareChief Medical Officer
|
SaleCommon Stock | 4,271 | $22.77 | $97,237.86 |
DisclosureSEC source: 0000899243-19-006916 · doc4.xml · nonDerivative · entry 1 Orlandi Cesare · CIK 0001610664 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,733 F1 · kind: Starting in 2019, the Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions under 10b5-1 plans. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2018, in part, to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.57 to $23.02, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| March 05, 2019 Filed Mar 6, 2019 21:30 UTC |
Heino Mary AnneDirector · President & CEO
|
SaleCommon Stock | 9,019 | $23.34 | $210,482.72 |
DisclosureSEC source: 0000899243-19-006444 · doc4.xml · nonDerivative · entry 2 Heino Mary Anne · CIK 0001610676 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 700,201 F1 · kind: Starting in 2019, the Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions under 10b5-1 plans. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2018, to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.05 to $23.80, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 21:30 UTC |
Heino Mary AnneDirector · President & CEO
|
SaleCommon Stock | 275 | $23.68 | $6,511.84 |
DisclosureSEC source: 0000899243-19-006444 · doc4.xml · nonDerivative · entry 1 Heino Mary Anne · CIK 0001610676 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 709,220 F1 · kind: Starting in 2019, the Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions under 10b5-1 plans. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2018, to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.